Chris is an experienced geneticist, biochemist, and entrepreneur.  Chris leverages a serial entrepreneur experience to bring into USA trials a cell therapy that is demonstrated in Canada to be safe and effective for Fabry patients. Under his leadership, Glafabra plans to extend their therapy platform and provide treatment options to patients with multiple genetic disorders.